Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Mehr anzeigen
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT PR Newswire NEW YORK, Dec. 30, 2024 NEW YORK, Dec. 30, 2024...
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire NEW YORK, Dec. 26, 2024 NEW YORK, Dec. 26, 2024 /PRNewswire/...
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024...
Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc...
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLT PR Newswire NEW YORK, Dec. 19, 2024 NEW YORK, Dec. 19, 2024...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0571 | -6.71527696107 | 0.8503 | 0.9 | 0.7726 | 5715262 | 0.86850411 | CS |
| 4 | -1.2568 | -61.3073170732 | 2.05 | 2.08 | 0.7726 | 10375737 | 1.26252343 | CS |
| 12 | -6.9568 | -89.7651612903 | 7.75 | 10.6237 | 0.7726 | 5470103 | 3.33891819 | CS |
| 26 | -3.8668 | -82.9785407725 | 4.66 | 10.6237 | 0.7726 | 3766128 | 4.55143591 | CS |
| 52 | -2.5568 | -76.3223880597 | 3.35 | 10.6237 | 0.7726 | 2662269 | 4.60857619 | CS |
| 156 | -7.9768 | -90.9555302166 | 8.77 | 10.6237 | 0.4995 | 1200927 | 3.90445384 | CS |
| 260 | -25.3468 | -96.9655700077 | 26.14 | 57.39 | 0.4995 | 777263 | 5.85109238 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
